Thiazolidinediones (PPARγ agonists) but not PPAR α agonists increase IRS‐2 gene expression in 3T3‐L1 and human adipocytes 1
The DOI matches its Crossref record.
Abstract
Thiazolidinediones (TZD) improve insulin sensitivity in human as well as in different animal models of insulin resistance and Type 2 diabetes. However, no clear link to the insulin signaling events has been identified. Using differentiated 3T3‐L1 adipocytes, we found that TZD rapidly and markedly increased IRS‐2 gene expression. This effect was specific for PPARγ agonists and was not seen with PPAR α agonists. It was rapidly induced (within 4 h) and maintained throughout the observation period of 48 h. It was also concentration dependent (EC 50 ~50 nM) and not inhibited by cycloheximide, suggesting a direct effect on the IRS‐2 promoter. There was no evidence that TZD altered IRS‐2 mRNA stability, supporting that the increased mRNA levels were due to an increased gene transcription. IRS‐2 protein expression was increased ~30% after 48 h and ~50% after 96 h. No effects of TZD were seen on IRS‐1, PKB/Akt, or GLUT4 gene expression. TZD also increased IRS‐2 mRNA levels in cultured human adipose tissue. These data show the first direct link between TZD and a critical molecule in insulin's signaling cascade in both 3T3‐L1 and human adipocytes, and indicate a novel mode of action of these compounds.—Smith, U., Gogg, S., Johansson, A., Olausson, T., Rotter, V., Svalstedt, B. Thiazolidinediones (PPARγ agonists) but not PPARa agonists increase IRS‐2 gene expression in 3T3‐L1 and human adipocytes. FASEB J. 15, 215–220 (2001)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The mechanisms of action of PPARs
Berger, J., & Moller, D. E. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104018 · Cited by 2,659
“Expression of IRS-2, a protein with a proven role in insulin signal transduction in insulin-sensitive tissue, was also increased in cultured adipocytes and human adipose tissue incubated with PPARγ agonists (77).”
BackgroundYki-Järvinen, H. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041001 · Cited by 1,830
Benson, S. C., Pershadsingh, H. A., Ho, C. I., Chittiboyina, A., Desai, P., Pravenec, M., Qi, N., Wang, J., Avery, M. A., & Kurtz, T. W. (2004) · Hypertension · doi:10.1161/01.hyp.0000123072.34629.57 · Cited by 1,073
Rotter, V., Nagaev, I., & Smith, U. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301977200 · Cited by 1,062
Self-citationPositive and negative regulation of insulin signaling through IRS-1 phosphorylation
Gual, P., Le Marchand-Brustel, Y., & Tanti, J.-F. (2005) · Biochimie · doi:10.1016/j.biochi.2004.10.019 · Cited by 912
The role of peroxisome proliferator-activated receptors (PPAR) in immune responses
Christofides, A., Konstantinidou, E., Jani, C., & Boussiotis, V. A. (2021) · Metabolism · doi:10.1016/j.metabol.2020.154338 · Cited by 720
Nuclear Receptors and the Control of Metabolism
Francis, G. A., Fayard, E., Picard, F., & Auwerx, J. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142528 · Cited by 636
PPARs: Fatty acid sensors controlling metabolism
Poulsen, L. L. C., Siersbæk, M., & Mandrup, S. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.01.003 · Cited by 510
PPARγ AND G LUCOSE H OMEOSTASIS
Picard, F., & Auwerx, J. (2002) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.22.010402.102808 · Cited by 411
Nagaev, I., & Smith, U. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5173 · Cited by 380
Self-citationPeroxisome Proliferator-Activated Receptor Targets for the Treatment of Metabolic Diseases
Monsalve, F. A., Pyarasani, R. D., Delgado-Lopez, F., & Moore-Carrasco, R. (2013) · Mediators of Inflammation · doi:10.1155/2013/549627 · Cited by 354
Tamori, Y., Masugi, J., Nishino, N., & Kasuga, M. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2045 · Cited by 294
PPARadigms and PPARadoxes: expanding roles for PPARγ in the control of lipid metabolism
Walczak, R., & Tontonoz, P. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30159-0 · Cited by 270
PPARγ-mediated insulin sensitization: the importance of fat versus muscle
Kintscher, U., & Law, R. E. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00440.2004 · Cited by 220
Kim, H.-I., & Ahn, Y.-H. (2004) · Diabetes · doi:10.2337/diabetes.53.2007.s60 · Cited by 194
Murdolo, G., Kempf, K., Hammarstedt, A., Herder, C., Smith, U., & Jansson, P. A. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03347440 · Cited by 58
Self-citation
Metadata
- Authors
- SMITH, U., GOGG, S., JOHANSSON, A., OLAUSSON, T., ROTTER, V., & SVALSTEDT, B.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2001-01
- Volume
- 15
- Issue
- 1
- Pages
- 215-220
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2074630167
- Cited by
- 132
- References
- 0
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.